Doctors Argue Sam Bankman-Fried’s Neurodivergence Hurt His Trial Defense
1 min read
A group of eight doctors specializing in neurodivergence submitted an amicus brief in support of Sam Bankman-Fried’s appeal, arguing that his autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) negatively impacted his trial proceedings, according to a report by Jesse Coghlan for Cointelegraph. In March, Bankman-Fried, co-founder of FTX, was sentenced to 25 years in
Source: CryptoGlobe
